(Q44103914)

29 November 2017

Cardiac function and metabolism in Type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-alpha activator (English)

1 reference

29 November 2017

Ellen Aasum

1

1 reference

29 November 2017

Darrell D Belke

2

1 reference

29 November 2017

David L Severson

3

1 reference

29 November 2017

Rudolph A Riemersma

4

1 reference

29 November 2017

Marie Cooper

5

1 reference

29 November 2017

Morten Andreassen

6

1 reference

29 November 2017

Terje S Larsen

7

1 reference

29 November 2017

1 September 2002

1 reference

American Journal of Physiology Heart and Circulatory Physiology

29 November 2017

1 reference

29 November 2017

283

1 reference

29 November 2017

H949-57

1 reference

29 November 2017

3

1 reference

Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth

29 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

PPAR signaling in the control of cardiac energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

Free fatty acids and pathogenesis of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

The effects of hypothalamics lesions in genetically diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

Insulin resistance and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce Adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

Roles of PPARs in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

Pyruvate dehydrogenase activity in cardiac mitochondria from genetically diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

Developmental changes in energy substrate use by the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

BM 17.0744: a structurally new antidiabetic compound with insulin-sensitizing and lipid-lowering activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

Pathophysiology of insulin resistance in human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

Metabolic disturbances in diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

Cardiac consequences of diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

Regulation of energy substrate metabolism in the diabetic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

21 January 2018

Ventricular energetics

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor (alpha) in the adult rodent heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

Lipotoxic heart disease in obese rats: implications for human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00226.2001

10.1152/AJPHEART.00226.2001

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference